Non-progression with avelumab treatment in patients with metastatic Merkel cell carcinoma (mMCC) is associated with a clinically meaningful better health-related quality of life compared with progressive disease Meeting Abstract
| Authors: | Bharmal, M.; Nolte, S.; Lebbé, C.; Mortier, L.; Brohl, A. S.; Fazio, N.; Grob, J. J.; Prinzi, N.; Hanna, G. J.; Hassel, J.; Kiecker, F.; Ellers-Lenz, B.; Bajars, M.; Guezel, G.; Nghiem, P.; Hunger, M.; Schlichting, M.; Henry-Szatkowski, M.; D'Angelo, S. |
| Abstract Title: | Non-progression with avelumab treatment in patients with metastatic Merkel cell carcinoma (mMCC) is associated with a clinically meaningful better health-related quality of life compared with progressive disease |
| Meeting Title: | ESMO Virtual Congress 2020 |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Sep 19-21/Oct 16-18 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-09-01 |
| Start Page: | S740 |
| End Page: | S741 |
| Language: | English |
| ACCESSION: | WOS:000573469101380 |
| DOI: | 10.1016/j.annonc.2020.08.1216 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1092P -- Source: Wos |
